An AI-Designed Drug Is Moving Toward Approval at an Impressive Clip

For the first time, an AI-designed drug is in the second phase of clinical trials. Recently, the team behind the drug published a paper outlining how they developed it so fast. Made by Insilico Medicine, a biotechnology company based in New York and Hong Kong, the drug candidate targets idiopathic pulmonary fibrosis, a deadly disease […]